
Olivier Elemento
@elementolab
Director, Englander Institute for Precision Medicine @WCMenglanderIPM, Associate Director @wcmc_ctsc & ICB, Co-Founder @volastratx & @onethreebiotech
ID: 464159257
https://eipm.weill.cornell.edu/ 14-01-2012 22:36:34
26,26K Tweet
6,6K Followers
955 Following



Very happy to share our new paper on LLM-based tumor board agents. Submitted August 2024, published in Nature Cancer today āŗļø Led by Dyke Ferber nature.com/articles/s4301ā¦

We're pleased to see our work on vascularized cardiac & liver organoids published in Science Magazine. Congrats to Oscar J. Abilez Huaxiao 'Adam' Yang and co-authors. Stanford CVI Stanford Medicine Stanford Department of Medicine Sarafan ChEM-H Greenstone Biosciences ā¦bi-nlm-nih-gov.laneproxy.stanford.edu/40472086/ med.stanford.edu/news/all-news/ā¦


Excited to share our study in Science Immunology dissecting the immune landscape of psoriatic arthritis (PsA)āwith a new finding: immunoproteasome overactivity drives treatment resistanceš§µ Led by Reut Tzemach,Chamutal Gur,T. San Phan,Eyal David & team. (1/11) science.org/doi/10.1126/scā¦



Review Article by Olivier Elemento, PhD (Olivier Elemento), Sean Khozin, MD, MPH, MD, and Cora N. Sternberg, MD (Cora Sternberg): The Use of Artificial Intelligence for Cancer Therapeutic Decision-Making nejm.ai/42N72gS


Was tipped off by Peter Steinberger about ccusage: github.com/ryoppippi/ccus⦠Super cool tool to track Claude Code costs in a fine grained way. Also works if logged in with Max plan, so you can compare if the $100/m or $200/m you spent per month actually pay off. Well.


A trial in patients with advanced breast cancer has found the use of liquid biopsy blood tests for early detection of a treatment-resistant mutation, followed by a new type of treatment, substantially extends the period of tumor control. Weill Cornell Medicine news.cornell.edu/stories/2025/0ā¦



Happening at EHA , results of the ASCERTAIN-V of oral decitabine and venetoclax in AML presented by Gail Roboz . The study met its primary endpoint ! Weill Cornell Leukemia





Dr. Teresa Sanchez (Teresa Sanchez, PhD) has been awarded the Established Investigator Award from American Heart Association. "It's recognition of our collaborative and interdisciplinary work," says Dr. Sanchez of Weill Cornell Medicine Pathology and WCM Brain and Mind Research Institute. Full story: bit.ly/4l8k7sZ


A stark warning from Jigar Shah & Raj Pannu in The New York Times: We are "sleepwalking into an infrastructure crisis." Our aging grid & insufficient energy generation can't power America's AI ambitions, especially as rivals invest heavily. Urgent action on both is a national priority.

Don't miss our next #PrecisionMedicine Research Conference, "A 26-Year Old Male with a Diagnosis of a Rare Malignant Tumor," presented by our WCM Englander Institute for Precision Medicine colleague Dr. Daniela Guevara on Thursday, June 26th at noon in Belfer 1401 and via Zoom (DM for details).
